INIS
cancer
100%
patients
97%
risks
83%
colombia
82%
genes
80%
breasts
80%
diseases
66%
genetics
58%
populations
43%
children
42%
mutations
42%
birth
38%
control
37%
congenital diseases
37%
humans
35%
defects
32%
receptors
29%
levels
29%
data
28%
proteins
22%
reviews
22%
surveillance
21%
women
20%
mortality
20%
phenotype
20%
blood
19%
tissues
16%
newborns
16%
viruses
15%
immunity
15%
hospitals
15%
vaccines
15%
ovaries
15%
estrogens
14%
congenital malformations
14%
losses
14%
lungs
14%
comparative evaluations
14%
screening
14%
hearings
13%
malformations
13%
information
13%
pregnancy
13%
dna
13%
cytokines
13%
adults
12%
tumors
12%
antibodies
12%
protection
11%
spectra
11%
variations
11%
management
10%
death
10%
mapping
10%
pediatrics
9%
dendrites
9%
inflammation
9%
plasma
9%
carriers
9%
males
9%
infants
9%
cities
9%
etiology
9%
diarrhea
8%
biological markers
8%
south america
8%
sex
8%
assessments
8%
immunoglobulins
8%
females
8%
correlations
8%
nervous system diseases
7%
exons
7%
developing countries
7%
mice
7%
symptoms
7%
bones
7%
lupus
7%
regulations
7%
recommendations
7%
evaluation
7%
distribution
7%
public health
7%
alcohols
7%
rna
7%
in vitro
7%
placenta
7%
therapy
6%
chromosomes
6%
nucleotides
6%
latin america
6%
detection
6%
origin
6%
corrections
6%
interactions
6%
mitochondria
6%
promoters
6%
prediction
6%
skin
6%
pathogenesis
6%
Medicine and Dentistry
Prevalence
36%
Congenital Malformation
32%
Breast Cancer
29%
Diseases
19%
Rotavirus
15%
Neonatal Infant
15%
Cancer Risk
15%
BRCA1
13%
Infection
13%
Congenital Disorder
11%
Case-Control Study
9%
Odds Ratio
9%
Hearing Impairment
8%
Ovarian Cancer
8%
BRCA2
8%
Diagnosis
8%
Pre-Eclampsia
7%
Health Care
6%
Central Nervous System
6%
Estrogen Receptor
6%
Estrogen Receptor Negative Breast Cancer
5%
Disorders of Sex Development
5%
Hypospadias
5%
Single Nucleotide Polymorphism
5%
Placenta
5%
T Cell
5%
B Cell
5%
Malignant Neoplasm
5%
Neoplasm
5%
Folic Acid
5%